Nakamoto, Shogo http://orcid.org/0000-0001-8043-8608
Watanabe, Junichiro http://orcid.org/0000-0001-9226-895X
Ohtani, Shoichiro
Morita, Satoshi
Ikeda, Masahiko
Article History
Received: 14 June 2021
Accepted: 15 October 2021
First Online: 2 November 2021
Competing interests
: Author Shogo Nakamoto has received lecture fees from Chugai Pharmaceuticals, Eisai Co., Ltd., and Taiho Pharmaceuticals outside the submitted work; Junichiro Watanabe has received lecture fees from AstraZeneca, Chugai Pharmaceuticals, Daiichi-Sankyo, Eisai Co., Ltd., Eli-Lilly, Novartis Pharma, Pfizer, and Taiho Pharmaceuticals outside the submitted work; Shoichiro Ohtani has received lecture fees from AstraZeneca, Chugai Pharmaceuticals, Eli-Lilly, and Pfizer outside the submitted work; Satoshi Morita has received lecture fees from Chugai Pharmaceuticals outside the submitted work; Masahiko Ikeda has received lecture fees from AstraZeneca, Chugai Pharmaceuticals, Daiichi-Sankyo, Eisai Co., Ltd., Eli-Lilly, Kyowa Kirin, Pfizer, Nippon Kayaku, Novartis, Mundipharma, Celltrion Healthcare, and Sawai Pharmaceuticals outside the submitted work.